About Us

About Us
 

Technology that combines health with innovation is here with you today for tomorrow.

Our company is established in 2020 as a manufacturer of the oil-based adjuvant systems, which are vaccine carriers that are needed in our country but supplied from other countries, and as a developer of information technologies and phase change materials. Since its establishment, Coral has carried out R&D studies and produced adjuvants used in vaccines by collaborating with veterinary vaccine industry components such as vaccine manufacturers, universities, veterinary institutes, and animal production farms.
While transforming new generation technologies into safe and effective products in the fields of carrier systems and information technologies, we never compromise on our principle of being affordable.

 
 
We are committed to developing veterinary health products and meeting the needs of our stakeholders with a constant stream of new and creative advancements. Our mission is to offer premium products at affordable prices while providing outstanding customer services.
 
 
OUR CERTIFICATES
 
 
01
2023

FEBRUARY

Within the scope of the quality management system, the documents were obtained from TÜV Rheinland®.

02
2022

DECEMBER

The project named “Adjuvant Production Used in Poultry Vaccines” was entitled to be supported within the scope of the Technology-Oriented Industry Move Program of the T.C. Ministry of Science, Industry and Technology.

03
2022

JULY

Coral Biotechnology production facility was established.

04
2022

JANUARY

R&D studies were strengthened with national and international project

05
2021

JUNE

Coral Biotechnology manufacturing facility was established.

06
2021

FEBRUARY

Collaborations started with leading universities to develop new adjuvants.

07
2020

DECEMBER

Coral Biotechnology Industry and Trade. Inc. was established.

08
2020

SEPTEMBER

Our adjuvant developed for poultry has been commercialized.

09
2019

AUGUST

First vaccine adjuvant studies for poultry started.

10
2017

SEPTEMBER

Positive results were obtained from in vivo studies of our adjuvants.

11
2015

AUGUST

First vaccine adjuvant studies were started in our R&D center.

 
Innovation
Innovation

We are committed to improving veterinary health products and meeting the needs of our stakeholders with a constant stream of new and creative developments. Our mission is to make premium products available while providing outstanding customer service.

MORE
 
Purpose

Delivering reliable, high-tech chemical products to future generations

Mission

Focusing on innovation, providing reliable animal health products and sustainable high-tech chemistry products

Vision

To be the pioneer and the most preferred business partner in the fields of activity.